DK3643795T3 - Fremganffremgangsmåde til bestemmelse af celle- eller vævsdød ved analyse af dna-methylering - Google Patents

Fremganffremgangsmåde til bestemmelse af celle- eller vævsdød ved analyse af dna-methylering Download PDF

Info

Publication number
DK3643795T3
DK3643795T3 DK19209237.7T DK19209237T DK3643795T3 DK 3643795 T3 DK3643795 T3 DK 3643795T3 DK 19209237 T DK19209237 T DK 19209237T DK 3643795 T3 DK3643795 T3 DK 3643795T3
Authority
DK
Denmark
Prior art keywords
analysis
dna methylation
determining cell
tissue death
death
Prior art date
Application number
DK19209237.7T
Other languages
Danish (da)
English (en)
Inventor
Yuval Dor
Ruth Shemer
Benjamin Glaser
Original Assignee
Yissum Research And Development Company Of The Hebrew Univ Of Jerusalem Ltd
Hadasit Med Res Service
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Research And Development Company Of The Hebrew Univ Of Jerusalem Ltd, Hadasit Med Res Service filed Critical Yissum Research And Development Company Of The Hebrew Univ Of Jerusalem Ltd
Application granted granted Critical
Publication of DK3643795T3 publication Critical patent/DK3643795T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK19209237.7T 2014-04-14 2015-04-14 Fremganffremgangsmåde til bestemmelse af celle- eller vævsdød ved analyse af dna-methylering DK3643795T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461979233P 2014-04-14 2014-04-14
EP15720481.9A EP3132055A2 (de) 2014-04-14 2015-04-14 Verfahren und kit zur bestimmung des gewebe- oder zellursprungs von dna

Publications (1)

Publication Number Publication Date
DK3643795T3 true DK3643795T3 (da) 2022-05-09

Family

ID=53051869

Family Applications (2)

Application Number Title Priority Date Filing Date
DK19209237.7T DK3643795T3 (da) 2014-04-14 2015-04-14 Fremganffremgangsmåde til bestemmelse af celle- eller vævsdød ved analyse af dna-methylering
DK22158931.0T DK4026917T5 (da) 2014-04-14 2015-04-14 Fremgangsmåde og kit til bestemmelse af cellers eller vævs død eller dna's vævs- eller celleoprindelse ved dna-methyleringsanalyse

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK22158931.0T DK4026917T5 (da) 2014-04-14 2015-04-14 Fremgangsmåde og kit til bestemmelse af cellers eller vævs død eller dna's vævs- eller celleoprindelse ved dna-methyleringsanalyse

Country Status (14)

Country Link
US (3) US11203784B2 (de)
EP (4) EP3643795B1 (de)
JP (1) JP6750879B2 (de)
CN (1) CN106574296B (de)
DK (2) DK3643795T3 (de)
ES (1) ES2974838T3 (de)
FI (1) FI4026917T3 (de)
HR (1) HRP20240189T1 (de)
IL (1) IL248299B (de)
LT (1) LT4026917T (de)
PL (1) PL4026917T3 (de)
PT (1) PT4026917T (de)
SI (1) SI4026917T1 (de)
WO (2) WO2015159293A2 (de)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160040229A1 (en) 2013-08-16 2016-02-11 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
US10876152B2 (en) 2012-09-04 2020-12-29 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
US11913065B2 (en) 2012-09-04 2024-02-27 Guardent Health, Inc. Systems and methods to detect rare mutations and copy number variation
CA2883901C (en) 2012-09-04 2023-04-11 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
EP3087204B1 (de) 2013-12-28 2018-02-14 Guardant Health, Inc. Verfahren und systeme für den nachweis genetischer varianten
PL4026917T3 (pl) 2014-04-14 2024-04-08 Yissum Research And Development Company Of The Hebrew University Of Jerusalem Ltd. Metoda i zestaw do określania śmierci komórek lub tkanek albo tkankowego lub komórkowego pochodzenia dna za pomocą analizy metylacji dna
DK3543356T3 (da) 2014-07-18 2021-10-11 Univ Hong Kong Chinese Analyse af methyleringsmønster af væv i DNA-blanding
US10689706B2 (en) 2015-07-20 2020-06-23 The Chinese University Of Hong Kong Methylation pattern analysis of haplotypes in tissues in a DNA mixture
CN108603228B (zh) 2015-12-17 2023-09-01 夸登特健康公司 通过分析无细胞dna确定肿瘤基因拷贝数的方法
US11384382B2 (en) 2016-04-14 2022-07-12 Guardant Health, Inc. Methods of attaching adapters to sample nucleic acids
WO2017181146A1 (en) 2016-04-14 2017-10-19 Guardant Health, Inc. Methods for early detection of cancer
US20190256921A1 (en) * 2016-05-04 2019-08-22 Queen's University At Kingston Cell-free detection of methylated tumour dna
KR102482616B1 (ko) * 2016-05-30 2022-12-28 더 차이니즈 유니버시티 오브 홍콩 혈액 내 무세포 dna를 사용하는 혈액 장애의 검출
US11499196B2 (en) 2016-06-07 2022-11-15 The Regents Of The University Of California Cell-free DNA methylation patterns for disease and condition analysis
US11124824B2 (en) 2016-08-17 2021-09-21 The Regents Of The University Of California Immunoprobe-based method to assess organ injury status through a biofluid-based cell-free DNA (CFDNA) assay
US11959125B2 (en) * 2016-09-15 2024-04-16 Sun Genomics, Inc. Universal method for extracting nucleic acid molecules from a diverse population of one or more types of microbes in a sample
AU2017347790B2 (en) 2016-10-24 2024-06-13 Grail, Inc. Methods and systems for tumor detection
KR20230062684A (ko) 2016-11-30 2023-05-09 더 차이니즈 유니버시티 오브 홍콩 소변 및 기타 샘플에서의 무세포 dna의 분석
CA3046007A1 (en) 2016-12-22 2018-06-28 Guardant Health, Inc. Methods and systems for analyzing nucleic acid molecules
EP4421489A2 (de) 2017-01-25 2024-08-28 The Chinese University of Hong Kong Diagnostische anwendungen unter verwendung von nukleinsäurefragmenten
WO2018187521A2 (en) 2017-04-06 2018-10-11 Cornell University Methods of detecting cell-free dna in biological samples
CN111032868A (zh) * 2017-06-30 2020-04-17 加利福尼亚大学董事会 用于评估无细胞dna中的dna甲基化的方法和系统
US20200165671A1 (en) * 2017-07-13 2020-05-28 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Detecting tissue-specific dna
EP3652343A1 (de) 2017-07-13 2020-05-20 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Digitale tröpfchen-pcr-strategie mit zwei sonden zur spezifischen detektion gewebespezifischer zirkulierender dna-moleküle
EP3652344A1 (de) 2017-07-13 2020-05-20 Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. Dna-targets als gewebespezifische methylierungsmarker
DE102017126248B4 (de) * 2017-11-09 2019-10-17 Epiontis Gmbh ERGIC1 als epigenetischer Marker zur Identifizierung von Immunzellen, insbesonderemonozytischem myeloid-abgeleiteten Suppressor-Zellen (mMDSCs)
WO2019159184A1 (en) * 2018-02-18 2019-08-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Cell free dna deconvolution and use thereof
TWI834642B (zh) 2018-03-13 2024-03-11 美商格瑞爾有限責任公司 異常片段偵測及分類
EP3766076A4 (de) * 2018-03-15 2021-12-29 Grail, Inc. Gewebespezifischer methylierungsmarker
CA3094717A1 (en) 2018-04-02 2019-10-10 Grail, Inc. Methylation markers and targeted methylation probe panels
WO2019209884A1 (en) 2018-04-23 2019-10-31 Grail, Inc. Methods and systems for screening for conditions
JP2021112127A (ja) * 2018-04-26 2021-08-05 暁生 黒田 膵β細胞の傷害検査方法
EP3801623A4 (de) 2018-06-01 2022-03-23 Grail, LLC Neuronale faltungsnetzsysteme und verfahren zur datenklassifizierung
CN113286881A (zh) 2018-09-27 2021-08-20 格里尔公司 甲基化标记和标靶甲基化探针板
GB2595076B8 (en) 2018-11-21 2023-08-23 Agilent Technologies Inc Methods for targeted nucleic acid library formation
US11581062B2 (en) 2018-12-10 2023-02-14 Grail, Llc Systems and methods for classifying patients with respect to multiple cancer classes
AU2019401636A1 (en) * 2018-12-18 2021-06-17 Grail, Llc Systems and methods for estimating cell source fractions using methylation information
US11902959B2 (en) * 2019-02-02 2024-02-13 Lenovo (Beijing) Limited Enhanced scheduling of time sensitive networking
IL265451B (en) 2019-03-18 2020-01-30 Frumkin Dan Methods and systems for the detection of methylation changes in DNA samples
US20220064731A1 (en) * 2019-04-03 2022-03-03 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Primers for multiplex pcr
US11773450B2 (en) 2019-04-03 2023-10-03 Grail, Llc Methylation-based false positive duplicate marking reduction
US11001898B2 (en) 2019-05-31 2021-05-11 Universal Diagnostics, S.L. Detection of colorectal cancer
US11396679B2 (en) 2019-05-31 2022-07-26 Universal Diagnostics, S.L. Detection of colorectal cancer
US11891653B2 (en) 2019-09-30 2024-02-06 Guardant Health, Inc. Compositions and methods for analyzing cell-free DNA in methylation partitioning assays
US11898199B2 (en) 2019-11-11 2024-02-13 Universal Diagnostics, S.A. Detection of colorectal cancer and/or advanced adenomas
AU2021213150A1 (en) 2020-01-30 2022-08-04 Prognomiq Inc Lung biomarkers and methods of use thereof
GB2612412A (en) 2020-01-31 2023-05-03 Avida Biomed Inc Systems and methods for targeted nucleic acid capture
CN115997035A (zh) 2020-06-30 2023-04-21 通用诊断股份公司 用于检测多种癌症类型的系统和方法
JP2024534992A (ja) 2021-09-13 2024-09-26 プログノミック インコーポレイテッド 生体分子の増強された検出および定量
US20230212674A1 (en) * 2021-12-30 2023-07-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Compositions and methods for identifying cell types
AU2023234529A1 (en) * 2022-03-15 2024-10-10 Resonant Llc Neuronal methylation signatures from cell free dna as a pre-symptomatic neurodegenerative condition surveillance diagnostic
WO2024038457A1 (en) 2022-08-18 2024-02-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. A method for determining the tissue or cell of origin of dna

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154600B (nl) 1971-02-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
NL154599B (nl) 1970-12-28 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking.
US3901654A (en) 1971-06-21 1975-08-26 Biological Developments Receptor assays of biologically active compounds employing biologically specific receptors
US3853987A (en) 1971-09-01 1974-12-10 W Dreyer Immunological reagent and radioimmuno assay
US3867517A (en) 1971-12-21 1975-02-18 Abbott Lab Direct radioimmunoassay for antigens and their antibodies
NL171930C (nl) 1972-05-11 1983-06-01 Akzo Nv Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen.
US3850578A (en) 1973-03-12 1974-11-26 H Mcconnell Process for assaying for biologically active molecules
US3935074A (en) 1973-12-17 1976-01-27 Syva Company Antibody steric hindrance immunoassay with two antibodies
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4034074A (en) 1974-09-19 1977-07-05 The Board Of Trustees Of Leland Stanford Junior University Universal reagent 2-site immunoradiometric assay using labelled anti (IgG)
US3984533A (en) 1975-11-13 1976-10-05 General Electric Company Electrophoretic method of detecting antigen-antibody reaction
US4098876A (en) 1976-10-26 1978-07-04 Corning Glass Works Reverse sandwich immunoassay
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US4879219A (en) 1980-09-19 1989-11-07 General Hospital Corporation Immunoassay utilizing monoclonal high affinity IgM antibodies
US5011771A (en) 1984-04-12 1991-04-30 The General Hospital Corporation Multiepitopic immunometric assay
US4666828A (en) 1984-08-15 1987-05-19 The General Hospital Corporation Test for Huntington's disease
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4801531A (en) 1985-04-17 1989-01-31 Biotechnology Research Partners, Ltd. Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
US5322770A (en) 1989-12-22 1994-06-21 Hoffman-Laroche Inc. Reverse transcription with thermostable DNA polymerases - high temperature reverse transcription
US5272057A (en) 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
US5192659A (en) 1989-08-25 1993-03-09 Genetype Ag Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
KR100236506B1 (ko) 1990-11-29 2000-01-15 퍼킨-엘머시터스인스트루먼츠 폴리머라제 연쇄 반응 수행 장치
CA2218875C (en) 1991-07-23 2000-11-07 The Research Foundation Of State University Of New York Improvements in the in situ pcr
US5281521A (en) 1992-07-20 1994-01-25 The Trustees Of The University Of Pennsylvania Modified avidin-biotin technique
US5612473A (en) 1996-01-16 1997-03-18 Gull Laboratories Methods, kits and solutions for preparing sample material for nucleic acid amplification
GB9620209D0 (en) 1996-09-27 1996-11-13 Cemu Bioteknik Ab Method of sequencing DNA
GB9626815D0 (en) 1996-12-23 1997-02-12 Cemu Bioteknik Ab Method of sequencing DNA
WO1999018124A1 (en) 1997-10-07 1999-04-15 Merck & Co., Inc. Assays for nuclear receptor ligands using fret
US6274320B1 (en) 1999-09-16 2001-08-14 Curagen Corporation Method of sequencing a nucleic acid
AU2002352143A1 (en) * 2001-11-23 2003-06-10 Epigenomics Ag Method and nucleic acids for the analysis of a lymphoid cell proliferative disorder
DE60207979T2 (de) * 2002-03-05 2006-09-28 Epigenomics Ag Verfahren und Vorrichtung zur Bestimmung der Gewebespezifität von freier DNA in Körperflüssigkeiten
US7709194B2 (en) * 2004-06-04 2010-05-04 The Chinese University Of Hong Kong Marker for prenatal diagnosis and monitoring
US8623599B2 (en) 2007-06-08 2014-01-07 Epigenomics Ag Method for methylation analysis
WO2011001728A1 (ja) 2009-07-01 2011-01-06 シャープ株式会社 アクティブマトリクス基板及び有機el表示装置
US9783850B2 (en) 2010-02-19 2017-10-10 Nucleix Identification of source of DNA samples
US9366632B2 (en) 2010-02-12 2016-06-14 Raindance Technologies, Inc. Digital analyte analysis
AU2011244084A1 (en) 2010-04-20 2012-11-15 Nucleix Methylation profiling of DNA samples
WO2012047091A1 (en) * 2010-10-08 2012-04-12 Universiti Putra Malaysia Glp-1 promoter mediated insulin expression for the treatment of diabetes
EP3444361A1 (de) * 2011-06-22 2019-02-20 Yale University Verfahren zur diagnose von erkrankungen und störungen in zusammenhang mit dem zelltod pankreatischer beta-zellen
US9127317B2 (en) 2012-03-02 2015-09-08 Winthrop-University Hospital Method for using probe based PCR detection to measure the levels of circulating demethylated β cell derived DNA as a measure of β cell loss in diabetes
CN104486990B (zh) 2012-07-20 2017-07-04 株式会社村田制作所 生物传感器
WO2014138133A1 (en) 2013-03-04 2014-09-12 Islet Sciences, Inc. Compositions and methods for detecting hypo-methylated dna in body fluids
WO2014149356A1 (en) 2013-03-15 2014-09-25 Abbott Molecular Inc. Detection of bisulfite converted nucleotide sequences
PL4026917T3 (pl) 2014-04-14 2024-04-08 Yissum Research And Development Company Of The Hebrew University Of Jerusalem Ltd. Metoda i zestaw do określania śmierci komórek lub tkanek albo tkankowego lub komórkowego pochodzenia dna za pomocą analizy metylacji dna
WO2015169947A1 (en) 2014-05-09 2015-11-12 Lifecodexx Ag Detection of dna that originates from a specific cell-type and related methods
US10858706B2 (en) 2015-07-10 2020-12-08 Nyu Winthrop Hospital System, method and kit for analysis of circulating differentially methylated DNA as a biomarker of beta-cell loss
US20200165671A1 (en) 2017-07-13 2020-05-28 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Detecting tissue-specific dna
EP3652343A1 (de) 2017-07-13 2020-05-20 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Digitale tröpfchen-pcr-strategie mit zwei sonden zur spezifischen detektion gewebespezifischer zirkulierender dna-moleküle
EP3652344A1 (de) 2017-07-13 2020-05-20 Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. Dna-targets als gewebespezifische methylierungsmarker

Also Published As

Publication number Publication date
IL248299A0 (en) 2016-11-30
PT4026917T (pt) 2024-02-12
EP4026917B1 (de) 2023-11-15
EP4026917A1 (de) 2022-07-13
IL248299B (en) 2021-04-29
DK4026917T5 (da) 2024-07-15
US20170121767A1 (en) 2017-05-04
JP6750879B2 (ja) 2020-09-02
EP3132055A2 (de) 2017-02-22
US20220064730A1 (en) 2022-03-03
WO2015159292A2 (en) 2015-10-22
EP4306659A2 (de) 2024-01-17
DK4026917T3 (da) 2024-02-12
PL4026917T3 (pl) 2024-04-08
WO2015159292A3 (en) 2015-12-10
EP3643795B1 (de) 2022-03-30
JP2017511142A (ja) 2017-04-20
WO2015159293A2 (en) 2015-10-22
EP3643795A1 (de) 2020-04-29
LT4026917T (lt) 2024-03-12
US20230242985A1 (en) 2023-08-03
FI4026917T3 (fi) 2024-02-14
HRP20240189T1 (hr) 2024-04-26
US11203784B2 (en) 2021-12-21
SI4026917T1 (sl) 2024-05-31
EP4306659A3 (de) 2024-03-27
CN106574296A (zh) 2017-04-19
ES2974838T3 (es) 2024-07-01
WO2015159293A3 (en) 2015-12-10
CN106574296B (zh) 2021-03-02

Similar Documents

Publication Publication Date Title
DK3643795T3 (da) Fremganffremgangsmåde til bestemmelse af celle- eller vævsdød ved analyse af dna-methylering
HK1255230A1 (zh) 用於管理、執行和分析實驗室實驗的系統和方法
DK3548652T3 (da) Fremgangsmåder til proteinanalyse
IL249618A0 (en) Methods and preparations for analyzing samples
DK3194612T3 (da) Fremgangsmåder til kvantitativ genetisk analyse af cellefrit dna
DK3408407T3 (da) Fremgangsmåder til påvisning af cpg-methylering af tumorafledt dna i blodprøver
SG10202108763UA (en) Methods and compositions for nucleic acid analysis
DK3543356T3 (da) Analyse af methyleringsmønster af væv i DNA-blanding
DK3325669T3 (da) Sammensætninger og fremgangsmåder til RNA-analyse
DK3224755T3 (da) Statistisk analysefremgangsmåde til bestemmelse af risiko ved filbaseret indhold
GB2556436B (en) Cell population analysis
LT3263715T (lt) Pavienių ląstelių transkriptomo analizės būdas
GB2598259B (en) Cell Population Analysis
DK3617324T3 (da) Størrelsesbaseret analyse af DNA til klassificering af cancer
DK3152316T3 (da) Prøveklargøring til nukleinsyreamplifikation
DK3384274T3 (da) Fremgangsmåder til prøvekarakterisering
DK3739061T3 (da) Methyleringsmønsteranalyse af haplotyper i væv i DNA-blanding
EP3709001C0 (de) Systeme und verfahren zur bestimmung der probenosmolarität
IL249395A0 (en) Quantitative analysis of transgenic proteins
DK3822365T3 (da) Platform til opdagelse og analyse af terapeutiske midler
DK3152332T3 (da) Fremgangsmåde til at analysere methylering
DK3237636T3 (da) Dobbelt-quenching analyse til multiplex detektion af målnukleinsyrer
HK1247370A1 (zh) 組織樣本分析技術
DK3204536T3 (da) Fremgangsmåde til analyse af RNA fra føtale ekstravilløse trophoblastceller
DK3320111T3 (da) Prøveklargøring til nukleinsyreamplifikation